Though only approved for cancer pain, Actiq is often prescribed off-label for other breakthrough pain.
(CEPHALON)
When the Usual Drugs Stop Working

How real patients experience and manage breakthrough pain Read more
More about pain medication
To address this problem, researchers have developed rapid-delivery drugs, including the so-called "narcotic lollipop," Actiq (oral transmucosal fentanyl citrate). Absorbed quickly through the mouth, Actiq can begin relieving pain within five minutes and lasts at least an hour.
Off-label use of the narcotic "lollipop"
There is some controversy surrounding Actiq. Approved in 1998 only for cancer patients already being treated with opioids, it has been widely prescribed "off-label"for unapproved usesto noncancer patients. One estimate put the percentage of off-label prescriptions at 80%.
Cephalon, the makers of Actiq, have now released another drug, Fentora, which also contains fentanyl and is approved for the same uses. Absorption is better and faster than Actiq; it doesn't use a lollipop, but a patented form of effervescence.
Andrea Cooper, 52, of Phoenix, Md., who has fibromyalgia and spinal degeneration, says she couldn't live without breakthrough-pain medication. "The doctors call it a rescue dose, and it truly is a rescue dose for me," says Cooper, who initially used Actiq but has now switched to Fentora.
Cooper is constantly vigilant for signs of breakthrough pain; she realizes that if it takes hold, calming her pain generally becomes more difficult. "The whole thing about pain medication and pain management is to keep it at a manageable level all the time, and not allow it to ever spike. It becomes much harder to get it down, like a kid who's eaten too much chocolate. It's hard to tie him down."






